Optimization of Treatment of Advanced Nonsmall Cell Lung Cancer Using Radiotherapy and Chemotherapy

PHASE3CompletedINTERVENTIONAL
Enrollment

251

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Non Small Cell Lung Cancer
Interventions
RADIATION

radiation

39 Gy in 13 daily fractions of 3 Gy

OTHER

Chemotherapy and radiotherapy

Chemotherapy followed by low dose palliative radiotherapy

DRUG

Chemotherapy

Chemotherapy given alone

OTHER

Palliative radiotherapy and chemotherapy

Low dose palliative radiotherapy followed by chemotherapy

Trial Locations (13)

Unknown

Instituto de Radiomedicine, Santiago

Affiliated Hospital of Ning Xia Medical College, Department of Radiation Oncology, Yinchuan

University of Zagreb Faculty of Medicine, Zagreb

Misr Oncology Center (MOC), Cairo

Tata Memorial Centre (TMC) Department of Atomic Energy (DAE), Mumbai

General Hospital Kuala Lumpur, Institute of Radiotherapy and Oncology, Kuala Lumpur

Sir Paul Boffa Hospital, Floriana

Ministère de la Santé, Institut National d'Oncologie Sidi Mohamed Ben Abdellah, Rabat

Nuclear Medicine Oncology and Radiotherapy Institute, Islamabad

Instituto Oncológico National, Panama City

Instituto Nacional de Enfermadades Neoplasicas Depto. De Radioterapia, Lima

University of Witwatersrand Johannesburg Hospital Dept of Radiation Oncology, Johannesburg

Institut de la Sante Publique, Institut National de Cancer Salah Azaiz, Tunis

All Listed Sponsors
lead

International Atomic Energy Agency

OTHER_GOV

NCT00864331 - Optimization of Treatment of Advanced Nonsmall Cell Lung Cancer Using Radiotherapy and Chemotherapy | Biotech Hunter | Biotech Hunter